Clinical Trials
158 trialsNOECHO
Skribe Medical
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
AstraZeneca
NARFI
University Hospital, Bordeaux
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
EMPOwer
University of Alberta
Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer
Semmelweis University
Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography
Yonsei University
SomaScreen
Amager Hospital
STOP-MED CTRCD
University Health Network, Toronto
ML-CardioTox
University Hospital, Caen
TREAT-HF
Virginia Commonwealth University
Advance Care Planning in the Emergency Department
Brigham and Women's Hospital
CardioNETPOL
National Institute of Cardiology, Warsaw, Poland
SCARF-1
Karolinska Institutet
Goal Concordant Care Learning Laboratory
Duke University
SCPC
University Hospital Muenster
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
Mayo Clinic
SEARCH-ED
NHS Greater Glasgow and Clyde
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
Lifestyle Intervention for Heart Failure
M.D. Anderson Cancer Center
BE-FITTER
University of Alberta
BREACH-fMRI
University Hospital, Geneva
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
M.D. Anderson Cancer Center
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure
M.D. Anderson Cancer Center
HIMALAYAS-P
University Health Network, Toronto
HIMALAYAS
University Health Network, Toronto
Alpaca
University Medical Centre Ljubljana
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Medical College of Wisconsin
CCTGuide Pilot
Abramson Cancer Center at Penn Medicine
Expanding Access to Home-Based Palliative Care
University of Southern California
Community Exercise Treating Effect on Cardiopulmonary Disease Patients
Guangdong Provincial People's Hospital
PICSI-P
University of Washington
Ehealth@H2H
University of Stavanger
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
West Virginia School of Osteopathic Medicine
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity
Universitätsklinikum Hamburg-Eppendorf
CLARITY
The Netherlands Cancer Institute
PICSI-H
University of Washington
EntMedPall
University Hospital Muenster
PACE-4-TAVI
Medical University of Silesia
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
Massachusetts General Hospital
JUSTIFY
Women's College Hospital
MoveStrong
University of Waterloo
Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions
Rigshospitalet, Denmark
SCHOLAR-2
Population Health Research Institute
PICSI-H
University of Washington
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
EMPOWER
Future Genetics Limited